Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO).


CETIN B., BENEKLI M., TURKER I., Koral L. , ULAS A., DANE F., ...More

Journal of chemotherapy (Florence, Italy), vol.26, pp.300-5, 2014 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 26
  • Publication Date: 2014
  • Doi Number: 10.1179/1973947813y.0000000147
  • Title of Journal : Journal of chemotherapy (Florence, Italy)
  • Page Numbers: pp.300-5
  • Keywords: Advanced breast cancer, Lapatinib, Capecitabine, HER2, ADJUVANT CHEMOTHERAPY, MONOCLONAL-ANTIBODY, 1ST-LINE TREATMENT, TRASTUZUMAB, EFFICACY, SAFETY, METASTASES, SURVIVAL, THERAPY, WOMEN